Almirall
Spain - BarcelonaBiotechnology
Focus: Almirall is a Spanish-headquartered specialty pharma company focused on small-molecule therapeutics in dermatology, immunology, infectious diseases, and oncology. The company maintains a portfolio of marketed dermatology assets with near-term patent cliff exposure.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About Almirall
AI assessmentNot HiringNo open roles listed right now. Follow Almirall to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Late-stage
14 Phase 3+
LOE Risk
2 imminent
ALTABAX
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
$3M Part DDeclining
LOE Approaching
Flagship product representing 32% of company revenue but lacks disclosed LOE date, creating urgent succession planning concern.
Help build intelligence for Almirall
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.